Merus B.v.
Clinical trials sponsored by Merus B.v., explained in plain language.
-
New drug duo aims to shrink lung tumors in First-Line trial
Disease control Recruiting nowThis phase 2 trial tests whether adding petosemtamab to the standard immunotherapy pembrolizumab can shrink tumors in adults with metastatic non-small cell lung cancer. About 180 participants will receive the combination as their first treatment. The study focuses on how many pat…
Phase: PHASE2 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for head and neck cancer: experimental drug petosemtamab enters final testing
Disease control Recruiting nowThis Phase 3 trial tests a new drug called petosemtamab against standard treatments (cetuximab, methotrexate, or docetaxel) in 600 adults with advanced head and neck cancer that has spread or come back. Participants must have already tried immunotherapy and chemotherapy. The main…
Phase: PHASE3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo therapy aims to boost survival in head and neck cancer
Disease control Recruiting nowThis study tests whether adding petosemtamab to the standard immunotherapy pembrolizumab helps people with advanced head and neck cancer live longer. About 700 adults with PD-L1 positive cancer that has spread or come back will receive either the combination or pembrolizumab alon…
Phase: PHASE3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC